June 13, 2009

from GlobalResearch Website

It looks like governments around the world will either force these vaccinations on the public or launch a massive propaganda campaign to trick you into submitting to a jab.

If they attempt to force these untested and essentially experimental vaccinations on you, cite the Nuremberg Code, which states:

“The voluntary consent of the human subject is essential.”

No experimental vaccine should be,

“conducted where there is an a priori reason to believe that death or disabling injury will occur, except, perhaps, in those experiments where the experimental physicians also serve as a subjects.”

In addition to the “experimental physicians” submitting to their own toxins, Obama, every member of Congress, the CEOs of the drug companies, all members of WHO and the United Nations, all members of the CFR and Bilderberg, etc., should submit to a jab.

A third party should be on hand to make sure these folks do not get a saline injection instead of the vaccine:

 (AFP, June12, 2009)
Swiss drugs giant Novartis has completed a first batch of swine flu vaccine for pre-clinical trials and aims to make a version available from September, the company said.

“Novartis has successfully completed the production of the first batch of influenza A(H1N1) vaccine, weeks ahead of expectations,” the company said. The 10-litre batch “will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials”.

Novartis hopes to start clinical trials in July and “expects licensure in the fall (September to November) of 2009″, it said. It added that “more than 30 governments have made requests to Novartis to supply them with influenza A(H1N1) vaccine ingredients.”

The company used cell-based technology to produce the vaccine, a faster method than the traditional technology that uses eggs, according to Novartis.

Read full AFP report below...

 

First swine flu vaccine ready for testing
From correspondents in Basel
Agence France-Presse
June 12, 2009

from News Website

SWISS drugs giant Novartis has completed a first batch of swine flu vaccine for pre-clinical trials and aims to make a version available from September, the company said.

"Novartis has successfully completed the production of the first batch of influenza A(H1N1) vaccine, weeks ahead of expectations," the company said.

The 10-litre batch,

"will be used for pre-clinical evaluation and testing and is also being considered for use in clinical trials".

Novartis hopes to start clinical trials in July and,

"expects licensure in the fall (September to November) of 2009", it said.

It added that,

"more than 30 governments have made requests to Novartis to supply them with influenza A(H1N1) vaccine ingredients."

The company used cell-based technology to produce the vaccine, a faster method than the traditional technology that uses eggs, according to Novartis.

Novartis received $US289 million ($352.96 million) last month from the US Department of Health and Human Services for the development of the vaccine. The World Health Organization (WHO) declared a swine flu pandemic today, ratcheting up its alert to the maximum level of six.

W.H.O declares official swine flu pandemic

Swine flu has infected almost 30,000 people in 75 countries and claimed 144 lives since it was first detected in Mexico in April.